1.24
price down icon3.13%   -0.04
after-market Dopo l'orario di chiusura: 1.24
loading

Regulus Therapeutics Inc Azioni (RGLS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
6.34%
8.826
8.30 8.125 7.315 7.369
Interest Income/Expense
28.95%
0.081
0.114 0.137 0.168 0.185
Operating Income/Loss
6.34%
-8.826
-8.30 -8.125 -7.315 -7.369
Income/Loss From Continuing Operations Before Tax
5.06%
-8.469
-8.061 -7.824 -7.012 -7.139
Income/Loss From Continuing Operations After Tax
5.06%
-8.469
-8.061 -7.824 -7.013 -7.139
Net Income/Loss
5.06%
-8.469
-8.061 -7.824 -7.013 -7.139
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
6,661%
28.75
0.4252 19.63 19.10 16.84
Diluted Average Shares
6,661%
28.75
0.4252 19.63 19.10 16.84
Basic Earnings Per Share
110.47%
-0.29
2.77 -0.40 -0.37 -0.42
Diluted Earnings Per Share
110.47%
-0.29
2.77 -0.40 -0.37 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$30.75
price down icon 0.65%
$71.93
price down icon 0.75%
$19.03
price up icon 4.62%
$358.93
price down icon 2.04%
biotechnology ONC
$210.08
price up icon 2.31%
$111.93
price down icon 0.74%
Capitalizzazione:     |  Volume (24 ore):